Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Share News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 12th Jun 2013 07:55

Aberdeen Asset Management: Canaccord Genuity cuts target price from 460p to 440p, while leaving its buy recommendation unchanged.ASOS: Canaccord Genuity downgrades to hold with a target price of 3400p.BT Group: Credit Suisse increases target price from 300p to 350p and maintains an outperform rating.Bunzl: Investec reinitiates with a target price of 1320p and an add rating.Dee Valley: Investec takes target price from 1385p to 1400p maintaining a hold recommendation.IG Group: UBS ups target price from 560p to 630p and stays with its buy recommendation. Espirito Santo moves target price from 650p to 662p and leaves its buy recommendation unaltered.Immunodiagnostic Systems Holdings: Canaccord Genuity downgrades to hold with an unchanged target price of 404p.Keller Group: Citi raises target price from 755p to 960p, while reiterating a neutral rating.Lloyds Banking Group: Barclays ups target price from 40p to 65p and upgrades from underweight to equal-weight.Microgen: Westhouse Securities moves target price from 140p to 155p, but downgrades from add to neutral.Moneysupermarket: Canaccord Genuity lowers target price from 226p to 213p staying with its buy recommendation.Prudential: Morgan Stanley shifts target price from 1191p to 1190p keeping an overweight rating.Rightmove: Deutsche Bank initiates with a target price of 2200p and a hold recommendation.Royal Bank of Scotland: Barclays raises target price from 300p to 370p upgrading from equal-weight to overweight.RPC Group: Canaccord Genuity ups target price from 440p to 470p and keeps its buy recommendation.SAB Miller: JP Morgan reduces target price from 4050p to 3520p, while leaving its overweight rating unchanged.SSE: Berenberg takes target price from 1430p to 1570p and retains its hold recommendation.
More News
21 Mar 2018 18:04

Immunodiagnostic Non-Executive Director Roland Sackers To Resign

LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC, a producer of manual and automated diagnostic testing kits and instruments for the clinical market, said that a

Read more
2 Feb 2017 15:23

Immunodiagnostic Launches New Assay In Hypertension Portfolio

Read more
20 Jan 2017 16:35

DIRECTOR DEALINGS: Immunodiagnostic Systems Non-Executive Buys Shares

Read more
19 Jan 2017 15:38

Immunodiagnostic Systems Holdings appoints new CEO

(ShareCast News) - Immunodiagnostic Systems Holdings (IDS), an AIM listed specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, has announced that its chief executive Patricio Lacalle will step down for personal reasons from 31 March 2017. Du

Read more
11 Jan 2017 16:20

DIRECTOR DEALINGS: Immunodiagnostic Systems Non-Executive Buys Shares

Read more
21 Oct 2016 10:28

Immunodiagnostic Systems expects stable revenues

(ShareCast News) - Immunodiagnostic Systems Holdings, the AIM listed specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, expects its revenue for the full year to be in line with the previous period. The group's unaudited revenue for the first

Read more
21 Jul 2016 15:04

UK Shareholder Meetings Calendar - Next 7 Days

Read more
21 Jul 2016 15:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
14 Jul 2016 15:08

UK Dividends Calendar - Next 7 Days

Read more
11 Jul 2016 12:14

DIRECTOR DEALINGS: Immunodiagnostic Systems Non-Executive Buys Shares

Read more
5 Jul 2016 09:30

DIRECTOR DEALINGS: Immunodiagnostic Systems Non-Executive Buys Shares

Read more
28 Jun 2016 17:18

DIRECTOR DEALINGS: Immunodiagnostic Non Executive Acquires Shares

Read more
28 Jun 2016 12:56

DIRECTOR DEALINGS: Immunodiagnostic Chief Executive Buys First Shares

Read more
23 Jun 2016 13:44

DIRECTOR DEALINGS: Immunodiagnostic Finance Boss Buys First Shares

Read more
22 Jun 2016 16:22

Immunodiagnostic revenues shrink as clients move on

(ShareCast News) - Immunodiagnostic Systems reported a 15.6% decline in revenues for the year to 31 March on Wednesday, to £38.3m. The AIM-traded firm said that excluding the acquisition of Diametra and at constant exchange rates the decline was even larger at 18.4%. Its board reported automated re

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.